June 11, 2020 / 11:39 AM / 24 days ago

BRIEF-Pluristem Announces Activation Of Clinical Sites And Commencement Of Patient Enrollment In U.S. FDA Phase II Covid-19 ARDS Trial

June 11 (Reuters) - Pluristem Therapeutics Inc:

* PLURISTEM ANNOUNCES ACTIVATION OF CLINICAL SITES AND COMMENCEMENT OF PATIENT ENROLLMENT IN U.S. FDA PHASE II COVID-19 ARDS TRIAL

* PLURISTEM THERAPEUTICS - PHASE II COVID-19 ARDS TRIAL IS EXPECTED TO INCLUDE UP TO 25 SITES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below